// App-Quantinova.ai

2115224 : OPTIMIZING P2Y12RECEPTOR INHIBITION IN ACUTE CORONARY SYNDROME PATIENTS AFTER PCI USING PLATELET FUNCTION TESTING: IMPACT OF PRASUGREL VERSUS HIGHDOSE CLOPIDOGREL

Researchers

Presenter

  • Daniel Aradi

Principal Investigators

  • Tunde Pinter

  • Balazs Magyari

  • Attila Konyi

  • Andras Vorobcsuk

  • Ivan G. Horvath

  • Andras Komocsi

Medical Centers

  • Pecs, Hungary

  • University of Pecs, Pecs, Hungary

Locations

  • Hungary

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Acute Coronary Syndromes

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Prasugrel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved